CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 1997 Publications

11-20  21-30  31-32

 

1. p53 tumor suppressor gene alterations in prostate cancer and potential p53 gene therapy approaches.
Srivastava S, Moul JW:
Molecular Urol.1:151-158, 1997.

 

2. Intracranial metastatic adenocarcinoma of the prostate presenting as visual disturbance.
Preston DM, Zeidman SM, Spevak M, Moul JW, Costabile RA:
Tech. In Urol., 3:51-53, 1997.

 

3. PSA thresholds for prostate cancer detection (letter).
Moul JW:
JAMA, 278:699, 1997.

 

4. Molecular genetics of the testicular cancer.
Moul JW:
J Urol, 157:1552-1553, 1997.

 

5. Increased risk of prostate cancer in African-American men.
Moul JW:
Molecular Urol. 1:119-127, 1997.

 

6. Epidemiology and screening for prostate cancer.
Moul JW:
Am. J. Managed Care.3(8):1200-1205, 1997.

 

7. Editorial: Radical prostatectomy and cryotherapy - some answers, more questions.
Moul JW
Journal of Urology, 157:256-257, 1997.

 

8. Prostate cancer-1997: Practicing what we preach.
Moul JW: Editorial:
J Urol, 158:1859-60, 1997.

 

9. What is proper cancer care in the era of managed care?
Moul JW:
Editorial to: Oncology, 11(1):72-78, 1997.

 

10. Prostate specific antigen in black and white men after hormonal therapies for prostate cancer.
Moul JW:
Editorial comment to: J Urol, 158:154, 1997.